119 related articles for article (PubMed ID: 11864793)
1. Urine testing to monitor adherence to TB preventive therapy.
Perry S; Hovell MF; Blumberg E; Berg J; Vera A; Sipan C; Kelley N; Moser K; Catanzaro A; Friedman L
J Clin Epidemiol; 2002 Mar; 55(3):235-8. PubMed ID: 11864793
[TBL] [Abstract][Full Text] [Related]
2. Use of the urine color test to monitor compliance with isoniazid treatment of latent tuberculosis infection.
Eidlitz-Markus T; Zeharia A; Baum G; Mimouni M; Amir J
Chest; 2003 Mar; 123(3):736-9. PubMed ID: 12628871
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Arkansas method of urine testing for isoniazid in South Africa.
Hanifa Y; Mngadi K; Lewis J; Fielding K; Churchyard G; Grant AD
Int J Tuberc Lung Dis; 2007 Nov; 11(11):1232-6. PubMed ID: 17958987
[TBL] [Abstract][Full Text] [Related]
4. The value of urine testing for verifying adherence to anti-tuberculosis chemotherapy in children and adults in Uganda.
Meissner PE; Musoke P; Okwera A; Bunn JE; Coulter JB
Int J Tuberc Lung Dis; 2002 Oct; 6(10):903-8. PubMed ID: 12365577
[TBL] [Abstract][Full Text] [Related]
5. Self-report INH adherence measures were reliable and valid in Latino adolescents with latent tuberculosis infection.
Blumberg EJ; Hovell MF; Kelley NJ; Vera AY; Sipan CL; Berg JP
J Clin Epidemiol; 2005 Jun; 58(6):645-8. PubMed ID: 15878479
[TBL] [Abstract][Full Text] [Related]
6. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.
Szakacs TA; Wilson D; Cameron DW; Clark M; Kocheleff P; Muller FJ; McCarthy AE
BMC Infect Dis; 2006 Jun; 6():97. PubMed ID: 16772037
[TBL] [Abstract][Full Text] [Related]
7. Point-of-care urine tests for smoking status and isoniazid treatment monitoring in adult patients.
Nicolau I; Tian L; Menzies D; Ostiguy G; Pai M
PLoS One; 2012; 7(9):e45913. PubMed ID: 23029310
[TBL] [Abstract][Full Text] [Related]
8. The reliability and practicality of the Arkansas method assay of isoniazid adherence.
Schmitz KE; Hovell MF; Wong CA; Kelley NJ; Nilsen D; Blumberg EJ; Hill LL; Sipan CL; Kolody B; Chatfield DA
Clin Nurs Res; 2010 May; 19(2):131-43. PubMed ID: 20435784
[TBL] [Abstract][Full Text] [Related]
9. Isoniazid/acetylisoniazid urine concentrations: markers of adherence to isoniazid preventive therapy in children.
Amlabu V; Mulligan C; Jele N; Evans A; Gray D; Zar HJ; McIlleron H; Smith P
Int J Tuberc Lung Dis; 2014 May; 18(5):528-30. PubMed ID: 24903787
[TBL] [Abstract][Full Text] [Related]
10. Low level of compliance with tuberculosis treatment in children: monitoring by urine tests.
Palanduz A; Gültekin D; Erdem E; Kayaalp N
Ann Trop Paediatr; 2003 Mar; 23(1):47-50. PubMed ID: 12648324
[TBL] [Abstract][Full Text] [Related]
11. Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania.
Shayo GA; Moshiro C; Aboud S; Bakari M; Mugusi FM
BMC Infect Dis; 2015 Aug; 15():368. PubMed ID: 26306511
[TBL] [Abstract][Full Text] [Related]
12. Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.
Guerra RL; Conde MB; Efron A; Loredo C; Bastos G; Chaisson RE; Golub JE
Respir Med; 2010 May; 104(5):754-7. PubMed ID: 20202806
[TBL] [Abstract][Full Text] [Related]
13. A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users.
Batki SL; Gruber VA; Bradley JM; Bradley M; Delucchi K
Drug Alcohol Depend; 2002 May; 66(3):283-93. PubMed ID: 12062463
[TBL] [Abstract][Full Text] [Related]
14. Urine color testing and isoniazid monitoring.
Cope GF; Whitfield R
Chest; 2003 Dec; 124(6):2405; author reply 2405. PubMed ID: 14665533
[No Abstract] [Full Text] [Related]
15. Monitoring compliance with antituberculous treatment by detection of isoniazid in urine.
Elizaga J; Friedland JS
Lancet; 1997 Oct; 350(9086):1225-6. PubMed ID: 9652571
[No Abstract] [Full Text] [Related]
16. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
Sterling TR; Brehm WT; Moore RD; Chaisson RE
Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
[TBL] [Abstract][Full Text] [Related]
17. Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.
Hawken MP; Meme HK; Elliott LC; Chakaya JM; Morris JS; Githui WA; Juma ES; Odhiambo JA; Thiong'o LN; Kimari JN; Ngugi EN; Bwayo JJ; Gilks CF; Plummer FA; Porter JD; Nunn PP; McAdam KP
AIDS; 1997 Jun; 11(7):875-82. PubMed ID: 9189212
[TBL] [Abstract][Full Text] [Related]
18. Urine color test to monitor isoniazid compliance: "pissin' in the wind"?
Hollender ES; Ashkin D; Narita M
Chest; 2003 Mar; 123(3):668-70. PubMed ID: 12628857
[No Abstract] [Full Text] [Related]
19. Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island.
Kwara A; Herold JS; Machan JT; Carter EJ
Chest; 2008 Apr; 133(4):862-8. PubMed ID: 18071014
[TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users.
Chaisson RE; Barnes GL; Hackman J; Watkinson L; Kimbrough L; Metha S; Cavalcante S; Moore RD
Am J Med; 2001 Jun; 110(8):610-5. PubMed ID: 11382368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
